ACHAOGEN, INC.

SOUTH SAN FRANCISCO, CA How do I update this listing?

Achaogen is based out of South San Francisco. Achaogen, Inc. provides biopharmaceutical products. The company discovers, develops, and commercializes antibacterials to treat multi-drug resistant and gram-negative infections. Achaogen serves customers in the United States.Whalewisdom has at least 94 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2017-05-16. The notice included securities offered of Equity

Create Alert

Contact Info

achaogen, inc.
1 TOWER PLACE
SOUTH SAN FRANCISCO CA    94080

Business Phone: 650-800-3636
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2017-05-16 D BIOTECHNOLOGY Equity 9,999,976 9,999,976 0
2016-06-14 D BIOTECHNOLOGY Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 32,769,984 25,449,987 7,319,997
2013-03-22 D BIOTECHNOLOGY Equity 30,683,703 18,905,707 11,777,996
2010-04-19 D BIOTECHNOLOGY Equity 56,413,706 35,360,873 21,052,833
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
ALAN B. COLOWICK subscription required
    DIRECTOR
BECKI FILICE subscription required
    EXECUTIVE OFFICER
BLAKE WISE subscription required
    EXECUTIVE OFFICER
BRYAN E. ROBERTS subscription required
    DIRECTOR
CAMILLE D. SAMUELS subscription required
    DIRECTOR
CHRISTINE WELCH subscription required
    EXECUTIVE OFFICER
CHRISTOPHER WALSH subscription required
    DIRECTOR
DENNIS HOM subscription required
    EXECUTIVE OFFICER
GARY LOEB subscription required
    EXECUTIVE OFFICER
GREGORY STEA subscription required
    DIRECTOR
HALLEY E. GILBERT subscription required
    DIRECTOR
HEINZ E. MOSER subscription required
    EXECUTIVE OFFICER
IAN R. FRIEDLAND subscription required
    EXECUTIVE OFFICER
J. KEVIN JUDICE subscription required
    EXECUTIVE OFFICER DIRECTOR
JOHN C. DOYLE subscription required
    EXECUTIVE OFFICER
JOHN F. HOLLWAY subscription required
    EXECUTIVE OFFICER
JOHN W. SMITHER subscription required
    DIRECTOR
JON B. BRUSS subscription required
    EXECUTIVE OFFICER
KENNETH J. HILLAN subscription required
    EXECUTIVE OFFICER DIRECTOR
KENNETH NUSSBACHER subscription required
    DIRECTOR
KENT LIEGINGER subscription required
    DIRECTOR
LEE SWEM subscription required
    EXECUTIVE OFFICER
MICHAEL FISCHBACH subscription required
    DIRECTOR
ROBERT MORE subscription required
    DIRECTOR
SCOTT ROCKLAGE subscription required
    DIRECTOR
THOMAS KING subscription required
    DIRECTOR
TOBIN C. SCHILKE subscription required
    EXECUTIVE OFFICER
TROY COX subscription required
    DIRECTOR
ZERYN SARPANGAL subscription required
    EXECUTIVE OFFICER

Elevate your investments